Hua Medicine Turns to 2025 Profit; Shares Soar 10%

MT Newswires Live

03/27

Hua Medicine (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.

Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.

Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.

The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2622846835"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2622846835\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2622846835?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 15:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622846835","market":"us","top_or_hot":-1,"title":"Hua Medicine Turns to 2025 Profit; Shares Soar 10%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/HUMDF\">Hua Medicine</a> (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.</p><p>Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.</p><p>Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.</p><p>The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hua Medicine Turns to 2025 Profit; Shares Soar 10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHua Medicine Turns to 2025 Profit; Shares Soar 10%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-03-27 15:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/HUMDF\">Hua Medicine</a> (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.</p><p>Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.</p><p>Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.</p><p>The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02552","symbol_name":"華領醫藥-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2622846835","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622846835","pubTimestamp":1774598343,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Hua Medicine   recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02552":"华领医药-B","BK1191":"制药","HUMDF":"Hua Medicine","BK1574":"生物医药B类股","BK4007":"制药"},"translate_title":"华领医药转2025年盈利；股价飙升10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HUMDF":1.5,"02552":1},"content_text":"Hua Medicine (Shanghai) (HKG:2552) recorded a profit of 1.11 billion yuan in 2025, compared with a loss of 250.1 million yuan a year prior, according to a Thursday Hong Kong bourse filing.Shares of the Chinese drugmaker were up over 10% in Friday afternoon trading.Earnings per share stood at 1.10 yuan for the period, compared with a loss per share of 0.25 yuan in the previous fiscal year.The pharmaceutical company's revenue surged to 492.9 million yuan from 255.9 million yuan previously, generated mainly from the sale of core product HuaTangNing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}